← All signals
Signal

cbdMD Acquires Twinlab to Scale Multi-Brand Platform Across Longevity and Women's Beauty

Category
· Ecosystem Shift · Global
Date
September 2, 2026
Source
OVUM

Summary

cbdMD has entered a definitive agreement to acquire legacy supplement provider Twinlab Brands, diversifying its portfolio into sports nutrition, weight loss, and beauty. This acquisition scales cbdMD's annual revenue to approximately $30 million and signals a strategic shift from pure-play CBD toward a broad wellness platform.

Positions inside Digital Health/Telehealth and Care Delivery are shifting, and the useful question is which neighbouring companies are affected. Watch for follow-on moves from the investors, incumbents, and new entrants named here.

OVUM interpretation layer

The editorial read on this signal — pattern, market-structure implications, and what to watch next.

Sources

The OVUM Intelligence Brief

Keep reading past this page

The week's funding, launches, and studies in women's health, in plain English.

Weekly. No spam. Unsubscribe anytime.